Healthcare -
Biotechnology - NASDAQ - US
$ 34.545
-0.619 %
$ 2.68 B
Market Cap
111.44
P/E
Price Target
Average
--8.81%
Revenue Forecast
Estimate
0.91%
EBIT
Estimate
--11.43%
Net Income
Estimate
--0.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Veracyte, Inc.
Wall Street analysts predict an average 1-year price target for VCYT of $31.5 , with forecasts ranging from
a
low of
$23 to a high of $44 .
VCYT Lowest Price Target
Wall Street Target
23 USD
-33.42%
VCYT Average Price Target
Wall Street Target
31.5 USD
-8.81%
VCYT Highest Price Target
Wall Street Target
44 USD
27.37%
REVENUE FORECAST
Revenue Forecast Chart VCYT
EBIT FORECAST
EBIT Forecast Chart VCYT
NET INCOME FORECAST
Net Income Chart VCYT